59 results about "Gastric hyperacidity" patented technology

The present invention relates to a composition comprising probiotic bacteria for use in the pharmacological treatment of gastric hyperacidity. Said composition is capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity and of minimizing the secondary effects due to said pharmacological treatment.

The invention discloses a compound omeprazole capsule, and a preparation method and a detection method thereof. The capsule is prepared by: in parts by weight, 20 parts of omeprazole, 1100 parts of sodium bicarbonate, 30 parts of cross linked sodium carboxymethyl cellulose and proper amount of magnesium stearate; or the capsule is prepared by 40 parts of omeprazole, 1100 parts of sodium bicarbonate, 30 parts of cross linked sodium carboxymethyl cellulose and proper amount of magnesium stearate. Aiming at the deficiency of the prior art The formulation, the preparation technology and the detection method of the conventional compound omeprazole capsule are optimized, the compound omeprazole capsule of the invention exhibits more substantial curative effect for diseases comprising peptic ulcer, gastroesophageal reflux disease and the like caused by gastric hyperacidity; a systematic, integrated and effective component discrimination and content determination method is established, thereby the medicine quality is effectively controlled, and thus the clinic curative effect is guaranteed.

The present invention relates to a Chinese medicine in treating gastropathy and its preparation method. Said medicine is prepared by making 16 Chinese medicinal materials of parched tangerine peel, ginger-processed pinellia tuber, raw saussurea root, amomum fruit shell, parched bitter orange and others as raw material and go through the process of decoction and extraction. Said medicine has the functions of smoothing the liver and regulating the circulation of qi, strengthening the spleen and stomach, warming the middle-jiao to dispel cold, reducing gastric hyperacidity to alleviate stomachache, promoting blood circulation and removing stasis and others.

The invention provides a compound omeprazole capsule, a preparation method and a detection method thereof. The capsule is prepared from the following components in accordance with parts by weight: 200 parts of omeprazole, 1100 parts of sodium bicarbonate and a right amount of magnesium stearate and talcum powder or 40 parts of omeprazole, 1100 parts of sodium bicarbonate and a right amount of magnesium stearate and talcum powder. According to the compound omeprazole capsule, the preparation method and the detection method aiming at the defects of the prior art, the preparation process of the compound omeprazole capsule is optimized, so that the compound omeprazole capsule has obvious curative effects on treating diseases such as peptic ulcers, gastroesophageal reflux diseases and the like which are caused by hyperchlorhydria, and a systemic, integral and effective component identification and content determination method is established, so that the quality of the compound omeprazole capsule can be effectively controlled, thereby guaranteeing the clinic curative effects of the compound omeprazole capsule.

The invention discloses a medicine compound for curing tummy bug, which including following ingredients and proportion: bismuth aluminic acid 100-300 shares, heavy magnesium carbonate 100-600 shares, sodium bicarbonate 100-400 shares, liquorice extractive powder 100-500 shares, frank mouse lippich 1-50 shares, fennel powder 1-50 shares, aloe powder 1-50 shares or / and grassleaved sweetflag rhizome 1-50 shares. It also discloses the manufacturing method for the medicine, the compound medicine is one compound preparation resisting acid and protecting gastric mucosa, it can be applied to cure stomach and duodenum abscess, chronic superficial gastritis, overmuch stomach acid, and nerve indigestion and so on.

A Chinese medicine for treating gastric ulcer, duodenal ulcer and chronic gastritis is prepared from 6 Chinese-medicinal materials including liquorice root, cuttlefish bone, white peony root, pilose asiabell root, etc. Its preparing process is also disclosed.

The invention discloses disodium sulfodehydroabietate (DSDA) and a composition, a preparation method and application thereof in medicaments for preventing hyperacid peptic ulcer and gastrointestinal inflammation. A patent application disclosed by CN00818150.0 is of the opinion that monosodium sulfodehydroabietate is superior to disodium salt, but does not further disclose test conditions and data conclusion; moreover, the pharmacological action and clinical application of the disodium salt deserve further research. The invention compares the in-vitro acid making effects of monosodium salt and the disodium salt, the dissolution of the monosodium salt and the disodium salt in artificial gastric juice and intestinal juice as well as the clinical efficacies in treating gastric ulcer, acute gastritis and acute attack of chronic gastritis. Results show that DSDA has the advantages that DSDA has stronger acid-making capability during treating the gastric ulcer, acute gastritis and acute attack of chronic gastritis and faster dissolution speed in stomach and intestine; and medicaments prepared from the DSDA have better curative effect and quick response.

A method of pharmaceutically managing snoring and impaired breathing is provided. This invention relates to treating snoring, sleep apnea, and other forms of sleep-disordered breathing in those with or without symptoms of or the diagnosis of gastro-intestinal reflux disease (GERD). It comprises administration of a therapeutically effective dose of Prevacid (Lansoprazole) or any other medication that can be used to treat symptoms of hyper-acidity or gastrointestinal reflux disease (GERD). The therapeutic medication may be used alone or in combination with other pharmacologic agents or mechanical modalities including but not limited to decongestants, antihistamines or mechanical nasal toilet. It also is of benefit in improving breathing disorders that are present while awake.

The present invention discloses a Chinese patent medicine compound chenxiangwei tablet and its preparation method. It is smade from rhubarb, tangerine peel, saussurea root, acorus root, sodium hydrogen carbonate, heavy magnesium carbonate and aluminium hydroxide as main raw material, adding starch and starch slurry as auxiliary material through a certain preparation process. Said invented tablet preparation has the functions of promoting circulation of qi, regulating the stomach, relieving gastric hyperacidity to alleviate stomachache and can be used for curing diseases of gastoduodenal ulcer, chronic gastritis and epigastralgia due to stagnation of qi, abdominal distention and eructation and acid regurgitation, etc.

The invention relates to a low-sugar Kouyanning tablet which belongs to the technical field of medical health-care products. The invention solves the technical problem of treating diabetic patients or patients with oral ulcer caused by gastrosia, acute and chronic pharyngitis and tonsillitis. The invention has the technical scheme that a few natural plants are used as flavoring agents of the low-sugar Kouyanning tablet, and the low-sugar Kouyanning tablet has reasonable composition and significant curative effect. The low-sugar Kouyanning tablet is mainly used for treating recurrent oral ulcer, acute and chronic pharyngitis, tonsillitis and the like.

The invention relates to the technical field of functional foods, in particular to a composition for relieving stomach illness and a preparation method thereof and a food for relieving stomach illness. The composition is prepared from the following main materials in parts by weight: 2.5 to 7.5 parts of probiotics, 2 to 3 parts of broccoli seed water extract, 10 to 25 parts of fermented soybean meal and 5 to 10 parts of Korean vegetable water extract concentrate. The composition has a good inhibition effect on helicobacter pylori, can relieve hyperacidity and repair ulcer, and is beneficial torecovery of gastric mucosa.

The invention discloses stomach nourishing medicinal liquor. The stomach nourishing medicinal liquor is prepared from the following chosen raw herbal materials: wild lilac, semen pharbitidis, ginger, mango leaves, agilawood, lindera aggregata, schisandra chinensis, dandelion, radix codonopsis, radix paeoniae rubra, sword beans, cinnamon, polygonum multiflorum and Chinese rice wine. The stomach nourishing medicinal liquor disclosed by the invention can be used for strengthening the spleen and nourishing the stomach, inhibiting gastrointestinal peristalsis and hyperacidity, repairing peptic ulcer and stopping gastrointestinal bleeding, and has very good effects of nourishing the stomach and strengthening the spleen, repairing stomach problems, promoting digestion and relieving stasis, treating spleen deficiency with dampness-heat, promoting urination and defecation and treating a stomachache.

The invention discloses a medicinal liquor for treating stomach diseases, which relates to a medicament preparation product and is used for increasing a variety for treating stomach diseases. Every dose of Chinese medicinal herb medicinal liquor preparation consists of the following medicinal materials by mass: 100g of swallowwortlike knotweed root, 10g of dandelion and 10mg of moschus, and is prepared by soaking the medicinal materials with 500g of corn liquor of which the alcoholic strength is over 55 degrees. A preparation method of the medicinal liquor comprises the following steps of: preparing medicinal materials including swallowwortlike knotweed root and dandelion according to the mass proportion in a formula; cleaning and drying in the air; adding moschus; mixing uniformly; soaking with 500g of corn liquor of which the alcoholic strength is over 55 degrees for a week till the liquor becomes yellow; and storing at a shady place. The medicinal liquor for treating stomach diseases disclosed by the invention does not have any side effect, is a simple, convenient, safe and quick-acting medicament, and can be clinically applied to patients suffering from various stomach diseases such as gastritis, hyperacidity, indigestion, epigastric pain, gastric and duodenal ulcer, gastric duodenobulbar ulcer, flautulence, singultus, gastric hemorrhage, and the like. The medicinal liquor has the advantages of capability of relieving pain and reducing inflammation for a patient suffering from stomach diseases, effective rate of over 95 percent, readily-available medicinal materials, low cost, simple preparation process and suitability for most patients suffering from stomach diseases.

The invention discloses a diuresis-promoting dampness-removing drug comprising the following raw materials in parts by mass: 3-7 parts of alpinia oxyphylla, 1-4 parts of sea horse, 2-5 parts of curcuma zedoary, 1-3 parts of Chinese mosla herb, 2-4 parts of dried rehmannia root, 3-6 parts of glechoma longituba, 1-5 parts of cuttlebone, 4-9 parts of coix seed and 2-8 parts of Chinese wax gourd peel. The diuresis-promoting dampness-removing drug has the efficacies of promoting diuresis and removing edema, tonifying spleen and removing dampness, relaxing muscles and tendons and eliminating arthralgia, clearing heat and eliminating pus, invigorating kidney and strengthening yang, strengthening qi and arresting seminal emission, promoting qi circulation and relieving pain, promoting blood circulation and removing blood stasis, stopping bleeding by astringency, arresting spontaneous emission and leukorrhagia, relieving gastric hyperacidity and healing sore.

Compositions and methods of losing weight are described that are suitable for individuals susceptible to gastric hyperacidity or gastroesophageal reflux. The compositions include in part a snack food having two or more rapidly digestible carbohydrates, in which the foodstuff or an aqueous mixture of the foodstuff and water has a pH equal to or greater than about 6, and in which the snack is substantially protein-free. The method of weight loss suitable for an individual with gastric hyperacidity includes substantially limiting the individual's caloric intake to about 1400 calories or less for women and 1800 calories or less for men in which the caloric intake includes one or more substantially protein-free snack foodstuffs having two or more rapidly digestible carbohydrates, in which an aqueous mixture of the foodstuff with water has a pH equal to or greater than about 6 and in which the individual loses weight.

The invention provides a novel medicine composition for preventing and treating chronic gastritis and relieving stomachache, heartburn and sour regurgitation caused by hyperacidity. The composition isa traditional Chinese medicine and western medicine compound preparation. The compound preparation mainly contains aluminum hydroxide, radix aucklandiae, a licorice root extract and a belladonna fluid extract. The composition improves the curative effect. The invention further provides a preparation method of a medicine for traditional Chinese medicine and western medicine combined treatment of chronic gastritis and diseases caused by hyperacidity. The preparation method comprises a prescription containing traditional Chinese medicine components, a preparation process of an adhesive, preparation of a soft material, preparation of wet granules and a drying technology. The production process is optimized.

The present invention refers to a composition comprising N-acetylcysteine and / or lysozyme; or N-acetylcysteine and microencapsulated gastroprotected lysozyme with probiotic bacteria for use in the pharmacological treatment of gastric hyperacidity. Said composition is capable of restoring the stomach's own barrier effect, which is lost during the pharmacological treatment of gastric hyperacidity, and of minimising the secondary effects due to said pharmacological treatment.

The invention discloses a drug for curing stomach disease. The drug for curing the stomach disease is obtained by processing a mixture of raw materials of, by weight, 140mg-155mg of metoclopramide tablets, 2200mg-2500mg of furazolidone tablets, 9600mg-10600mg of dried yeast tablets and 3300mg-3900mg of chenxiang lubailu tablets. A preparation method of the drug for curing the stomach disease includes: firstly, grinding the mixture of the above raw materials into powder, and then performing microbiological detection on the powder, and finally encapsulating the power if the powder is qualified in the microbiological detection. The drug for curing the stomach disease uses the common western medicine materials as the raw materials, is simple in preparation process and low in production cost, has effects of strengthening and consolidating body resistance, and relieving acid and pain, is mainly used to cure the stomach disease of gastric cavity pain, hyperacidity, congestion, edema and the like, caused by liver-stomach disharmony, and can alleviate symptoms of pain, megrim, chest distress and the like, caused by the stomach disease.

The invention discloses a combinatorial drug for treating gastrointestinal tract diseases, which comprises the following raw materials in part by weight: 2-10 parts of liquorice, 3-15 parts of fructus evodiae, 3-8 parts of common vladimiria root, 3-8 parts of rheum officinale, 2-15 parts of radix paeoniae alba, 5-10 parts of amomum tsao-ko, and 5-15 parts of pericarpium citri reticulatae. The combinatorial drug for treating gastrointestinal tract diseases has no toxic or side effect; is safe and stable in efficacy, stable and durable in curative effect, high in cure rate, and simple in preparation process; is a simple, convenient, safe and quick effective medicine; can be used for treating patients suffering from various gastric diseases, such as gastritis, hyperchlorhydria, dyspepsia, epigastric pain, peptic ulcer, gastrorrhagia and the like, and has popularization and use values.

The invention provides a drug for curing gastric colic, intestinal colic and renal colic. The drug is characterized in that the raw medicines according to the parts by weight are provided as follows: 10 to 20 shares of elecampane, 20 to 30 shares of rhizoma atractylodis, 10 to 20 shares of large angiopteris rhizome, 20 to 30 shares of dragon blood and 25 to 40 shares of china root. The drug has the functions for promoting digestion, regulating the flow of qi and relieving the pain, dimishing inflammation to stop diarrhea, settling the stomach and staunching, etc., and has good curative effects on the symptoms such as deficiency cold in spleen and stomach, indigestion, anorexia, gastroxynsis, abdominal distention, bellyache, laxness, constipation, hematochezia and vomit, particularly on the chronic gastritis, superficial gastritis, chronic colitis, constipation, haemorrhoid haemorrhage, indigestion and laxness, additionally on kidney pyema and renal colic caused by kidney stone.

The invention discloses a method for preparing hydrotalcite, which comprises the following steps: adding a reaction material mixed alkali solution (containing OH<->and CO3<2->) into a reaction systemin a dispersive dropwise adding manner to react, thereby obtaining a hydrotalcite raw material with excellent acid production capacity, and keeping the pH value between 3 and 5 for a long time. When the prepared preparation product is used for treating hyperacidity, the excellent performance of generating a lasting anti-acid clinical curative effect is shown. And the preparation method is simple to operate, high in yield and suitable for industrial large-scale production.

The invention belongs to traditional Chinese medicine, and particularly relates to a stomach-reducing capsule for treating stomach diseases, which is composed of twelve traditional Chinese medicine ingredients, by weight: 3 parts of angelica, 3 parts of almond, 3 parts of divine music, 3 parts of malt, and 3 parts of betel nut 3 parts of tangerine peel, 3 parts of frankincense, 3 parts of myrrh, 3 parts of woody fragrance, 3 parts of cinnamon, 3 parts of radish seed, 3 parts of licorice. , hyperacidity and other stomach diseases, the cure rate is as high as 98% or more; it is simple to make, convenient to take, has no toxic side effects, and has a high cure rate.

The invention relates to a novel 5-(2-fluorophenyl)-N-methyl-(3-pyridylsulfonyl)-1H-pyrrole-3-methyl ammonium acetate polymorph and describes a preparation method of each polymorph. The medicine is mainly used for treating erosive esophagitis, gastric ulcer, duodenal ulcer and helicobacter pylori and eliminating indications, and treating related diseases caused by hyperacidity.

The invention provides a 1-(5-(2-fluorophenyl)-1-3-(3-methoxypropoxy)benzenesulfonyl chloride)-1H-pyrrol-3-yl)-N-methylamine salt type. The salt type contains organic acid salt and inorganic acid salt. By mainly screening various organic acids and inorganic acids, 1-(5-(2-fluorophenyl)-1-3-(3-methoxypropoxy)benzenesulfonyl chloride)-1H-pyrrol-3-yl)-N-methylamine hydrochloride and 1-(5-(2-fluorophenyl)-1-3-(3-methoxypropoxy)benzenesulfonyl chloride)-1H-pyrrol-3-yl)-N-methylamine fumarate which have relatively high purities and relatively good stabilities can be obtained and can be used for treating erosive esophagitis, gastric ulcer, duodenal ulcer and helicobacter pylori, eradicating adaptation diseases and treating relevant diseases caused by hyperacidity.

The invention relates to a traditional Chinese medicinal compound preparation for treating gastric diseases and belongs to the field of traditional Chinese medicines. The traditional Chinese medicinal compound preparation is prepared from the following bulk drugs in a certain weight ratio: dried tangerine peel, frankincense, folium artemisiae argyi, tribulus terrestris, semen raphani, purple perilla, pseudo-ginseng, galangal and liquorice. The preparation can be tablets, pills, granules or capsules or other preparations, and has an excellent treatment effect on spleen-stomach deficiency, pains due to gastric coldness, hyperacidity, gastric ulcer, duodenal ulcer and other diseases.

A medication for hyperacidity is provided and consists of seven ingredients to bring about improvements in a patient with hyperacidity. The ingredients are soybeans, vegetables, milk, butter fats, whole wheat, fruits and magnesium citrate.

The invention discloses disodium sulfodehydroabietate (DSDA) and a composition, a preparation method and application thereof in medicaments for preventing hyperacid peptic ulcer and gastrointestinal inflammation. A patent application disclosed by CN00818150.0 is of the opinion that monosodium sulfodehydroabietate is superior to disodium salt, but does not further disclose test conditions and dataconclusion; moreover, the pharmacological action and clinical application of the disodium salt deserve further research. The invention compares the in-vitro acid making effects of monosodium salt andthe disodium salt, the dissolution of the monosodium salt and the disodium salt in artificial gastric juice and intestinal juice as well as the clinical efficacies in treating gastric ulcer, acute gastritis and acute attack of chronic gastritis. Results show that DSDA has the advantages that DSDA has stronger acid-making capability during treating the gastric ulcer, acute gastritis and acute attack of chronic gastritis and faster dissolution speed in stomach and intestine; and medicaments prepared from the DSDA have better curative effect and quick response.

The present invention refers to a combination of hyaluronic acid, chondroitin sulfate in combination with at least one antacid agent, in particular magaldrate, for the prevention or treatment of gastric hyperacidity and gastroesophageal reflux and related pathologies thereof. More particularly, the combination is used for the preparation of oral compositions with at least one pharmaceutical carrier and advantageously that comprise a bioadhesive agent as well.